Evidence map›Paper›PMID 37047338›Full record

ArticleInternational journal of molecular sciences2023

Investigation of the Entry Pathway and Molecular Nature of σ1 Receptor Ligands.

Gianmarco Pascarella, Lorenzo Antonelli, Daniele Narzi, Theo Battista, Annarita Fiorillo, Gianni Colotti, Leonardo Guidoni, Veronica Morea, Andrea Ilari

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Gianmarco PascarellaInstitute of Molecular Biology and Pathology (IBPM), National Research Council of Italy (CNR), 00185 Rome, Italy.ORCID 0000-0002-8382-8158
Lorenzo AntonelliInstitute of Molecular Biology and Pathology (IBPM), National Research Council of Italy (CNR), 00185 Rome, Italy.
Daniele NarziDepartment of Physical and Chemical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0003-2731-6286
Theo BattistaProtein Production Facility, Structural Biology Laboratory, Elettra Sincrotrone Trieste, 34149 Basovizza, Italy.
Annarita FiorilloDepartment of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, 00185 Roma, Italy.ORCID 0000-0002-8966-8554
Gianni ColottiInstitute of Molecular Biology and Pathology (IBPM), National Research Council of Italy (CNR), 00185 Rome, Italy.ORCID 0000-0002-9913-0635
Leonardo GuidoniDepartment of Physical and Chemical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-2497-9482
Veronica MoreaInstitute of Molecular Biology and Pathology (IBPM), National Research Council of Italy (CNR), 00185 Rome, Italy.ORCID 0000-0003-2566-3049
Andrea IlariInstitute of Molecular Biology and Pathology (IBPM), National Research Council of Italy (CNR), 00185 Rome, Italy.ORCID 0000-0002-7754-399X
Institute of Molecular Biology and Pathology · ITUniversity of L'Aquila · ITElettra-Sincrotrone Trieste S.C.p.A. · ITSapienza University of Rome · IT

Funding

CNCCS FOE 2021Ministero della Salute RF-2016-02364123 RAREST-JHDMinistry of Education, Universities and Research PRIN: 2017483NH8_005
6 · The paper itself

Abstract

The σ1 receptor (σ1-R) is an enigmatic endoplasmic reticulum resident transmembrane protein implicated in a variety of central nervous system disorders and whose agonists have neuroprotective activity. In spite of σ1-R's physio-pathological and pharmacological importance, two of the most important features required to fully understand σ1-R function, namely the receptor endogenous ligand(s) and the molecular mechanism of ligand access to the binding site, have not yet been unequivocally determined. In this work, we performed molecular dynamics (MD) simulations to help clarify the potential route of access of ligand(s) to the σ1-R binding site, on which discordant results had been reported in the literature. Further, we combined computational and experimental procedures (i.e., virtual screening (VS), electron density map fitting and fluorescence titration experiments) to provide indications about the nature of σ1-R endogenous ligand(s). Our MD simulations on human σ1-R suggested that ligands access the binding site through a cavity that opens on the protein surface in contact with the membrane, in agreement with previous experimental studies on σ1-R from

Indexed as

Molecular Dynamics SimulationReceptors, sigmaBinding SitesHumansLigandsProtein BindingSigma-1 ReceptorSteroidsLigandsReceptors, sigmaSigma-1 ReceptorSteroidsfluorescence titrationHuntington’s diseasemolecular dynamicsvirtual screeningσ1 receptor

Identifiers

PMID37047338
PMCPMC10094450
OpenAlexW4361204841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.